Daniel P. Silver
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 2%
Papers in
-
- DNA Repair Mechanisms 10
- CRISPR and Genetic Engineering 4
- Epigenetics and DNA Methylation 3
- Oncology 16
- PARP inhibition in cancer therapy 7
- Cancer-related Molecular Pathways 4
- Co-authors
- David M. Livingston (9 shared papers)Eugenia Spanopoulou (3 shared papers)David Baltimore (3 shared papers)Ralph Scully (2 shared papers)Ronald A. DePinho (3 shared papers)Andrea L. Richardson (5 shared papers)Zoltán Szállási (5 shared papers)Nicolai J. Birkbak (5 shared papers)
- Journals
- Cancer Research (3 papers)Cancer Discovery (3 papers)Clinical Cancer Research (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Cell (2 papers)
- Partner nations
- United StatesDenmarkFrance
In The Last Decade
Daniel P. Silver
35 papers receiving 4.0k citations
Daniel P. Silver's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 1.5k
- Cancer Research 591
- Molecular Biology 2.6k
- Genetics 888
- Immunology 643
Countries citing papers authored by Daniel P. Silver
This map shows the geographic impact of Daniel P. Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Silver more than expected).
Fields of papers citing papers by Daniel P. Silver
This network shows the impact of papers produced by Daniel P. Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Silver. The network helps show where Daniel P. Silver may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel P. Silver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects Hit paper breakdown → | 2004 | 646 |
| 2 | Stable Interaction between the Products of the BRCA1 and BRCA2 Tumor Suppressor Genes in Mitotic and Meiotic Cells Hit paper breakdown → | 1998 | 508 |
| 3 | Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents Hit paper breakdown → | 2012 | 428 |
| 4 | 1994 | 387 | |
| 5 | 2001 | 249 | |
| 6 | 2002 | 240 | |
| 7 | 2015 | 188 | |
| 8 | BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. | 1999 | 173 |
| 9 | 2009 | 163 | |
| 10 | 2001 | 151 | |
| 11 | 1993 | 146 | |
| 12 | 2010 | 135 | |
| 13 | 2012 | 107 | |
| 14 | 1995 | 87 | |
| 15 | 2004 | 70 | |
| 16 | p16(INK4a) and p53 deficiency cooperate in tumorigenesis. | 2002 | 52 |
| 17 | 2015 | 50 | |
| 18 | 2018 | 48 | |
| 19 | 2004 | 35 | |
| 20 | 2017 | 35 |
About Daniel P. Silver
Daniel P. Silver is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Epidemiology, having authored 36 papers that have together received 4.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), BRCA gene mutations in cancer (9 papers), PARP inhibition in cancer therapy (7 papers), Cancer-related Molecular Pathways (4 papers), CRISPR and Genetic Engineering (4 papers), Cancer Genomics and Diagnostics (3 papers), Epigenetics and DNA Methylation (3 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (591 citations), Molecular Biology (2.6k citations), Genetics (888 citations) and Immunology (643 citations). Daniel P. Silver has collaborated with scholars based in United States, Denmark and France. Frequent co-authors include David M. Livingston, Eugenia Spanopoulou, David Baltimore, Ralph Scully, Ronald A. DePinho, Andrea L. Richardson, Zoltán Szállási, Nicolai J. Birkbak, Aron C. Eklund and Zhigang C. Wang. Their work appears in journals such as Cancer Research, Cancer Discovery, Clinical Cancer Research, Bioorganic & Medicinal Chemistry Letters and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.